BioProspect Limited is an Australian company engaged in developing and commercialising natural products and technology in the human health and personal care, animal health and nutrition and agricultural sectors.

BioProspect also holds an investment in Frontier Oil Corporation, a Philippines-based oil and gas explorer.

ASX/Media Announcements

April 2013
Appendix 4C

Corporate Governance Policy Update

Update Frontier Oil SC55

February 2013

Appendix 3B

Half-Yearly Report to 31 December 2013

Update on Frontier Oil Investment

January 2013
Appendix 4C Qtr ended 31 December 2012

Frontier Update

December 2012
Update on Frontier Oil 
November 2012
Results of Annual General Meeting

Update on Frontier Oil

ASXCGC Diversity Statement Updated

Initial Director's Interest Notice

Final Director's Interest Notice

Director Appointment/Resignation

Annual Report to Shareholders

October 2012
Appendix 4C - Quarterly

Update on Frontier Oil

Notice of Annual General Meeting

Becoming a Substantial Shareholder

Results of Rights Issue

Market Update Frontier Oil Investment - Correction

Market Update Frontier Oil Investment  

September 2012
Result of Rights Issue

Change of Company Secretary

Final Annual financial statements y/e June 2012

Supplementary Prospectus

Amendment to Rights Issue

Final Director's Interest Notice

Director Resignation

Letter to security holders

Appendix 3B Rights Issue Prospectus

Rights Issue Prospectus

Company update and Appendix 3B

August 2012
Preliminary Final Report and Appendix 4E

Frontier Gasfields/Frontier Oil update

Share placement and Appendix 3B

July 2012

Appendix 4C June qtr

Capital Raising Initiatives

June 2012
Frontier Gasfields Investment Update

Appendix 3B

 

May 2012

Nassiping No 2 SC 52 gas appraisal well update

Convertible Notes Issue

April 2012
Appendix 4C 31 March 2012

Update Frontier Gasfields projects

Appendix 3X

Director Appointment

 

February 2012

Half year Financial Report

Nassiping -2 (SC52) progress drilling report

Issue of convertible notes

Nassiping -2 (SC52) progress drilling report

Capital raising initiatives

Nassiping -2 (SC52) progress drilling report

Appendix 3B

Nassiping-2 (SC52) progress drilling report

Nassiping-2 (SC52) progress drilling report

Management changes and change of registered office

Frontier drill rig Nassiping -2 (SC52) spuds

Update Frontier drill rig Nassiping -2 (SC52)

Market Update

Review of Corporate Governance Procedures

January 2012
Appendix 4C 31 December 2011

Response to Otto Energy comments

AGRIPRO development update

Frontier Gasfields update on Philippines drilling prospects

December 2011
Change of Director's Interest Notice
November 2011
Results of AGM
October 2011
Appendix 4C Sept qtr 2011

Notice of AGM and Proxy Form

Annual Report to Shareholders

Update Frontier's Philippines SC52 gas exxploration

Change of Registered Office

GI-GUARD Oral Paste in horses update

September 2011
Final Statutory accounts

Appendix 3B

Sept issue of Bionews

Final director's interest notice

Initial Director's interest notice

Appointment of Director

Resignation of Director

August 2011
Preliminary final report

Convertible Note Issue

Appendix 3B

Increase in shareholding in Frontier Gasfields

Final Director's Interest Notice

July 2011
Appendix 4C June qtr

3D Seismic survey completed on Frontier's SC6 project

Appendix 3B

Frontier's Philippines SC52 gas exploration advance

Appendix 3B

Middle East agreements for AGRIPRO and GI-Guard

Resignation of Director

Frontier investment finalised

Appendix 3Y MQ

Appendix 3Y CP

Appendix 3Y AL

Appendix 3Y JK

Appendix 3B

Appendix 3B

Results of Extraordinary General Meeting

June 2011
Re Gen Wellness Products newsletter

Notice of extraordinary general meeting 8 July

May 2011
Frontier Gasfields extension of exclusivity period
April 2011
Completion of due diligence Frontier Gasfields

March issue of Bionews

March 2011
Update on Frontier Gasfields due diligence 31 March

Update on Frontier Gasfields due diligence 10 March

Response to ASX on BPO announcement 3 March

New investment into gas assets

February 2011
Appendix 4D and half year accounts

Appendix 3X J Khouri

GI-GUARD Oral Paste Development update

Appointment of Director

Placement and Appendix 3B

Distribution agreement for REGEN products

January 2011
Appendix 4C 31 December 2010

Appendix 3B